Correction (DOI:10.1016/j.clpt.2004.10.015);Modulation of celecoxib pharmacokinetics by food in pediatric patients [2]

Clinical Pharmacology and Therapeutics

Volumn 77, Issue 3, 2005, Pages 226-228

  Stempak, Diana ^a   Gammon, Janet ^a   Halton, Jacqueline ^b   Champagne, Martin ^c   Koren, Gideon ^a   Baruchel, Sylvain ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CELECOXIB;

ANTIANGIOGENIC ACTIVITY; AREA UNDER THE CURVE; BRAIN DISEASE; CARDIOVASCULAR SYMPTOM; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DATA ANALYSIS; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; FOOD; HEMOCONCENTRATION; HUMAN; LETTER; LIPID DIET; LONG TERM CARE; MEDICAL LITERATURE; PEDIATRICS; PRIORITY JOURNAL; SIDE EFFECT; SOLID TUMOR; TOXICITY;

EID: 13944274200     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1016/j.clpt.2006.05.001     Document Type: Erratum

References (3)

1. D. Stempak, J. Gammon, J. Klein, G. Koren, S. Baruchel Single-dose and steady-state pharmacokinetics of celecoxib in children Clin Pharmacol Ther 72 2002 490 497
2. Celecoxib (SC-58635): a cyclooxygenase-2-specific inhibitor of inflammatory prostaglandin production [investigational brochure]. 6th ed. Skokie (IL): Searle; 1999.
3. Celebrex (celecoxib capsules) [prescribing information]. Skokie (IL): Searle, Pfizer; 2001.